Titer testing in everyday practice: facts behind the myths

Serologic testing for core vaccine antibodies is becoming more common in everyday veterinary practice, yet a few persistent myths still cause confusion. Current research, including long-term duration-of-immunity studies and large serosurveys, shows that antibody titers are a reliable tool for personalizing vaccination, avoiding unnecessary boosters, and building stronger trust with clients. Here are 5 of the most common myths, clarified with the evidence we have today:

Myth 1: “Titer testing only measures humoral immunity, not cell-mediated immunity, so it cannot reliably indicate protection.”

It is true that antibody tests measure only humoral immunity, but for several core viral diseases, that’s exactly the part of the immune system that matters most. For systemic, mainly extracellular viruses like canine parvovirus (CPV-2), canine distemper virus (CDV), canine adenovirus-1 (CAdV-1), and feline panleukopenia virus (FPV), neutralizing antibodies are the main driver of sterilizing immunity. Challenge-of-immunity studies clearly show this: when antibody levels are above established protective thresholds, infection is prevented right at the point of entry.^1,2

Large serosurveys back this up. In both dogs and cats, most vaccinated animals maintain antibody levels associated with protection for years, and their titers match what we expect to see in real-world immunity.³^,⁴ A study published in 2010 further demonstrated how durable this immunity can be, dogs vaccinated once at 16 weeks or older maintained protective immunity for 9–14 years, and challenge studies showed they were still fully protected even when antibody levels had dropped but were still detectable.⁵

Although low titers don’t completely rule out cell-mediated immune memory, we currently have no practical way to measure case mix index (CMI). So revaccinating titer-negative animals is still recommended as a precaution. Even so, using titers greatly reduces unnecessary revaccination and allows for better, more individualized risk assessment.

Myth 2: “If titers are measured yearly, how do we know they won’t drop below protective levels in a few months?”

If MLV core vaccine–induced immunity truly faded within just a few months, the widely accepted 3-year booster recommendations wouldn’t be considered safe. In reality, the evidence consistently shows that modified-live (MLV) core vaccines create strong, long-lasting immunity, often for many years.¹^-⁵

A large study of 1027 Italian dogs found that most remained seroprotected for CPV-2, CDV, and CAdV-1 for up to 3 years after vaccination, and over half were still seropositive even when more than 3 years had passed.³ Feline serosurveys show a similar picture, with FPV antibodies persisting for more than 18 years in some cats.⁴ These field data match long-term controlled trials: The 2010 study demonstrated that dogs vaccinated with MLV core vaccines maintained protective antibody levels for 10 to 14 years, and challenge studies showed complete protection 9 years after vaccination, even when serum antibody titers had declined.⁵

Because most dogs and cats remain protected for such long periods, periodic titer testing isn’t about catching a sudden collapse in immunity a few months after testing. Instead, it helps you pick out the exceptions, the minority of animals whose antibody levels wane earlier than expected, or those that never fully seroconverted in the first place. This lets you focus revaccination on the pets who truly need it, while avoiding unnecessary boosters and still feeling confident about long-term protection for the rest.

Myth 3: “Titer testing cannot be used in very young animals.”

Titer testing can actually be helpful at any age, including for puppies and kittens. Maternally derived antibodies (MDAs) can stick around longer than expected, sometimes past 16 weeks, and interfere with vaccination. That’s why current World Small Animal Veterinary Association guidelines recommend checking immunity after the vaccine series; serologic testing is really the only practical way to confirm that a young animal has truly seroconverted.¹^,²

Both canine and feline serosurveys show that some puppies and kittens finish their vaccine series without developing adequate titers, and a few rare ‘nonresponder’ puppies fail to mount protective immunity at all.^3,4 Identifying these animals early allows clinicians to adjust vaccine plans and give owners clearer guidance.

Myth 4: “Titer testing strengthens vaccine hesitancy.”

In practice, the opposite usually happens. Titer testing actually helps reduce hesitancy because it makes the vaccination process more transparent for clients. When owners can see clear, evidence-based results showing whether their pet is protected, they feel more confident that vaccines are being recommended thoughtfully, not automatically. Titer testing doesn’t replace vaccination, it complements it.

Point-of-care (POC) antibody testing has been shown to support good clinical decision-making and improve communication with clients. In fact, one study reported that using POC testing to guide booster decisions can help avoid unnecessary procedures and even improve client trust.⁴

Myth 5: “Titer tests, especially point-of-care tests, are unreliable.”

Lab-based tests like virus neutralization and hemagglutination inhibition are the gold standards for measuring core vaccine antibodies. But today’s POC titer tests can offer big advantages—they’re quick, convenient, and let you make immunity-based decisions right in the exam room. That said, not all POC tests are created equal, and reliability really comes down to choosing a test that has been properly validated.

In a Journal of the American Veterinary Medical Association study, one validated POC dot-blot ELISA (VacciCheck) showed high sensitivity (96%), strong specificity (87%–94%), and overall accuracy above 93%, closely matching gold-standard lab methods.² When a POC test has been evaluated this thoroughly, it can be a very dependable clinical tool.

So while POC testing can be incredibly useful, the key is selecting a test with solid data behind it—good sensitivity and specificitymatter. With the right test, POC titers are both practical and trustworthy in everyday practice.

References

1. Ford RB. Antibody testing vs vaccination: applications in clinical practice. Biogal. 2019. Accessed March 31, 2026. https://www.biogal.com/wp-content/uploads/2019/10/Antibody-Testing-vs.-Vaccination-Richard-B.-Ford-DVM.pdf
2. Egerer A, Larson L. Point-of-care Dot-Blot ELISA accuracy study. J Am Vet Med Assoc. 2022;260(15):1928-1933. doi:10.2460/javma.22.05.0224
3. Dall’Ara P, Lauzi S, Zambarbieri, et al. Serum antibody titers against core vaccine antigens in Italian dogs. Life. 2023;13(2):587. doi:10.3390/life13020587.
4. Dall’Ara P, Lauzi S, Turin L, et al. Serum antibody titers against core vaccine antigens in Italian cats. Life. 2023;13(12):2249. doi:10.3390/life13122249.
5. Schultz RD, Theil B, Mukhtar E, Sharp P, Larson LJ. Age and long-term protective immunity in dogs and cats. J Comp Pathol. 2010;142:S102–S108. doi:10.1016/j.jcpa.2009.10.009.